
Semax is a useful case for the research-chemical vs prescription-pharmaceutical distinction, because — like Tesamorelin — its story includes real pharmaceutical history in another market, which makes precision important. Broadly, substances handled in the UAE fall into different regulatory buckets: licensed medicines that have completed formal drug registration and are marketed under an approved brand for a specific therapeutic indication; controlled or scheduled substances under narcotics legislation; and unscheduled research chemicals supplied for laboratory and research purposes, labelled as not for human consumption.
The research-grade Semax that REVIVE LAB UAE supplies sits in the third category — sold as an HPLC-verified research reference material, not as a registered medicine.
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a fragment of ACTH, and it does have a documented pharmaceutical history: it has been registered and marketed as a prescription nasal-spray product in Russia and some neighbouring countries for a specific indication, manufactured under pharmaceutical standards and distributed through licensed channels there. That is a separate product, supply chain, and regulatory approval entirely from the research-grade Semax peptide sold by REVIVE LAB UAE for laboratory research.
REVIVE does not sell the Russian-registered pharmaceutical product, does not claim any equivalence to it, and does not make therapeutic or nootropic claims about the research material it supplies. The research-grade vial is a laboratory reagent — HPLC-verified for identity and purity, labelled research-use-only — not a substitute for, or version of, a licensed pharmaceutical product. Because REVIVE's Semax is not marketed or sold as a prescription drug in the UAE, and has no equivalent UAE drug registration, it generally falls into the unscheduled research-chemical category.
This is a general description of how the two channels differ conceptually, not a specific legal ruling for any individual shipment or use case. For certainty on your own circumstances, consult UAE customs, MOHAP, or a qualified lawyer rather than relying on this article alone.
Separately from the classification question, anyone bringing any product into the UAE personally — pharmaceutical, supplement, or research chemical — is generally responsible for understanding the documentation, declarations, and permits their specific shipment may require, and for how customs treats that parcel on arrival. International personal shipments can be held for verification of contents, origin, and labelling, and the buyer typically carries that administrative load directly.
REVIVE LAB UAE holds Semax in stock domestically and ships from inside the UAE, so a purchase is a domestic transaction rather than an international parcel the buyer has to personally declare and clear. This removes the customs uncertainty, delay risk, and paperwork that comes with ordering research chemicals from overseas vendors directly — one of the practical reasons UAE research groups increasingly prefer sourcing locally.
REVIVE's Semax listings are deliberately scoped: research-use-only labelling on every vial, no therapeutic or nootropic claims, no reference to the Russian pharmaceutical product as an equivalent, and no dosing or clinical-use guidance anywhere on the site. REVIVE does not claim MOHAP drug registration or any pharmaceutical marketing authorisation for this or any product — it operates strictly as a laboratory research-material supplier, and buyers are responsible for using the material in line with their own research context and applicable law.
| Spec | Detail |
|---|---|
| Form | Lyophilised powder, 10 mg vial |
| Molecular weight | ≈813 Da |
| Purity (HPLC) | ≥98.5% |
| Class | Heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) |
| Labelling | Research use only — not for human or veterinary use |
| Price | AED 249 per 10 mg vial |
Research-grade Semax supplied for laboratory and research purposes is generally classified as an unscheduled research chemical rather than a controlled substance or licensed prescription pharmaceutical in the UAE. This is general information, not legal advice — confirm specifics with UAE customs, MOHAP, or a qualified lawyer for your situation.
Semax has a licensed pharmaceutical history as a registered prescription nasal-spray product in Russia and some neighbouring markets — a separate, differently regulated product and channel from the research-grade peptide REVIVE supplies, which has no equivalent UAE registration.
Buying from a UAE-based supplier already holding domestic stock avoids the customs paperwork, delays, and interception risk of personal international shipments.
No. REVIVE does not claim MOHAP registration or any Russia-equivalent approval — it supplies HPLC-verified research material with clear non-human-consumption labelling.